Skip to main content

Table 2 Sensitivity and Specificity of Sputum Xpert Ultra by HIV status and prior history of TB, in Kampala, Uganda

From: The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda

 

Overall (n=698)a

Without prior TB (n=610)

With prior TBb (n=88)

Sensitivity

Specificity

Sensitivity

Specificity

Sensitivity

Specificity

Total Cohort

(N=336 with TB, 362 without TB)

90.5

(86.8, 93.4)

98.1

(96.1, 99.2)

90.9

(87.1, 93.9)

98.7

(96.6, 99.6)

85.7

(67.3, 96)

95

(86.1, 99)

HIV-negative (N=222 with TB, 212 without TB)

90.8

(86.3, 94.1)

98.8

(96.5, 99.8)

91.4

(87.0, 94.8)

99.5

(97.4, 100)

81.3

(54.4, 96)

94.6

(81.8, 99.3)

HIV-positive

(N=86 with TB,

90 without TB)

89.8

(82.0, 95.0)

96.5

(91.2, 99.0)

89.5

(81.1, 95.1)

96.7

(90.6, 99.3)

91.7

(61.5, 99.8)

95.7

(78.1, 99.9)

CD4 < 100

(N=25 with TB,

15 without TB)

96.2

(80.4, 99.9)

95.0

(75.1, 99.9)

96.0

(79.6, 99.9)

93.3

(68.1, 99.8)

100

(2.5, 100)

100

(47.8, 100)

CD4 ≥100

(N=61 with TB,

75 without TB)

87.5

(77.6, 94.1)

96.8

(90.9, 99.3)

86.9

(75.8, 94.2)

97.3

(90.7, 99.7)

90.9

(58.7, 99.8)

94.4

(72.7, 99.9)

  1. aSensitivity and specificity presented as percentage with 95% CI
  2. bGreater than one year from enrollment date